Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2026-01-27 @ 6:10 AM
Study NCT ID:
NCT02973503
Status:
COMPLETED
Last Update Posted:
2020-10-01
First Post:
2016-10-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis
Sponsor:
University Hospital, Clermont-Ferrand
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-11
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-14
First Submit QC Date:
None
Study First Post Date:
2016-11-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-06-30
Results First Submit QC Date:
None
Results First Post Date:
2020-09-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-09
Last Update Post Date:
2020-10-01
Last Update Post Date Type:
ACTUAL